Abstract
Objective: To analyze the scientific evidence regarding the relationship between the use of electronic smoking devices and the biological mechanisms associated with lung cancer risk. Methods: This is an integrative literature review structured according to PRISMA recommendations and based on the PICO strategy. The bibliographic search was conducted in the PubMed database using the descriptors Electronic Nicotine Delivery Systems, Smoking, and Lung Neoplasms, combined through Boolean operators. Studies published between 2020 and 2025 were included, totaling nine articles in the final sample. Results: The analyzed studies demonstrated that exposure to aerosols from electronic smoking devices may induce oxidative stress, chronic inflammation, epigenetic alterations, DNA damage, immune dysfunction, and proliferative changes consistent with mechanisms involved in pulmonary carcinogenesis. Experimental evidence also identified tumor-promoting potential and impairment of respiratory homeostasis. Final considerations: Although current evidence does not allow a definitive causal relationship between exclusive electronic smoking device use and increased lung cancer incidence, these products should not be considered biologically inert, reinforcing the need for longitudinal studies and public health regulatory measures.
References
ABELIA XA, et al. Comparison impact of cigarettes and e-cigs as lung cancer risk inductor: a narrative review. European Review for Medical and Pharmacological Sciences, 2023; 27(13): 6301–6318.
BALS R, et al. Electronic cigarettes: a task force report from the European Respiratory Society. European Respiratory Journal, 2019; 53(2): 1801151.
BOCCUTO L, MUKHOPADHYAY S. E-cigarette or vaping product use-associated lung injury (EVALI): review and update. Journal of Clinical Medicine, 2022; 11(3): 680.
BRAZNELL S, et al. What can current biomarker data tell us about the risks of lung cancer posed by heated tobacco products? Nicotine & Tobacco Research, 2024; 26(3): 270–280.
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). Outbreak of lung injury associated with e-cigarette use, or vaping. Atlanta: CDC, 2024.
CHAND HS, et al. Pulmonary toxicity and the pathophysiology of electronic cigarette, or vaping product, use associated lung injury (EVALI). Toxics, 2023; 11(2): 134.
ELTORAI AEM, et al. Impact of electronic cigarettes on various organ systems. Respiratory Care, 2019; 64(3): 328–336.
GLANTZ SA, BAREHAM DW. E-cigarettes: use, effects on smoking, risks, and policy implications. Annual Review of Public Health, 2018; 39: 215–235.
GONIEWICZ ML, et al. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine & Tobacco Research, 2017; 19(2): 160–167.
GOTTS JE, et al. What are the respiratory effects of e-cigarettes? BMJ, 2019; 366: l5275.
HERZOG C, et al. Cigarette smoking and e-cigarette use induce shared DNA methylation changes linked to carcinogenesis. Cancer Research, 2024; 84(11): 1898–1914.
HIKISZ P, JACENIK D. The tobacco smoke component, acrolein, as a major culprit in lung diseases and respiratory cancers: molecular mechanisms of acrolein cytotoxic activity. Cells, 2023; 12(6): 879.
INSTITUTO NACIONAL DE CÂNCER (INCA). Cigarro eletrônico: o que sabemos?. Rio de Janeiro: INCA, 2024.
LEE PN, et al. Estimating lung cancer risk from e-cigarettes and heated tobacco products: applications of a tool based on biomarkers of exposure and of potential harm. Harm Reduction Journal, 2025; 22(45): 1–22.
MCNEILL A, et al. Evidence review of e-cigarettes and heated tobacco products 2022. London: UK Health Security Agency, 2022.
NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE. Public health consequences of e-cigarettes. Washington, DC: The National Academies Press, 2018.
RAYNER RE, et al. Cigarette smoke preparations, not electronic nicotine delivery system preparations, induce features of lung disease in a 3D lung repeat-dose model. American Journal of Physiology – Lung Cellular and Molecular Physiology, 2021; 320(2): L276–L287.
REDELMEIER DA, CHATTERJEE A. Lung injury from electronic cigarettes and vaping: a systematic review. Canadian Medical Association Journal, 2020; 192(45): E1311–E1316.
RICE SJ, et al. Guidance on the clinical management of electronic cigarette or vaping-associated lung injury. Journal of Thoracic Oncology, 2020; 15(11): 1727–1737.
SAHU R, et al. E-cigarettes and associated health risks: an update on cancer potential. Advances in Respiratory Medicine, 2023; 91(6): 516–531.
SNODERLY HT, et al. E-cigarette use: device market, study design, and emerging evidence of biological consequences. International Journal of Molecular Sciences, 2021; 22(22): 12452.
TELLEZ CS, et al. Flavored e-cigarette product aerosols induce transformation of human bronchial epithelial cells. Lung Cancer, 2023; 179: 107180.
VELASCO WV, et al. Comparative effects of combustible cigarette versus electronic cigarette exposures on KRAS mutant lung cancer promotion. Neoplasia, 2025; 67: 101185.
WALLEY SC, et al. Electronic nicotine delivery systems: a policy statement from the American Academy of Pediatrics. Pediatrics, 2019; 143(5): e20190297.
WANG Q, et al. E-cigarette use and lung cancer screening uptake. JAMA Network Open, 2024; 7(7): e2419648.
WERLEY MS, et al. Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers. Nicotine & Tobacco Research, 2016; 18(12): 2289–2297.
WORLD HEALTH ORGANIZATION (WHO). WHO report on the global tobacco epidemic 2023: protecting people from tobacco smoke. Geneva: World Health Organization, 2023.
XIE W, et al. Association of electronic cigarette use with respiratory symptom development among U.S. young adults. American Journal of Respiratory and Critical Care Medicine, 2023; 208(4): 425–433.
